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ABSTRACT
Background. Few studies have investigated the gut microbiome of infants, fewer still
preterm infants. In this studywe sought to quantify and interrogate the resistomewithin
a cohort of premature infants using shotgun metagenomic sequencing. We describe
the gut microbiomes from preterm but healthy infants, characterising the taxonomic
diversity identified and frequency of antibiotic resistance genes detected.
Results. Dominant clinically important species identified within the microbiomes
included C. perfringens, K. pneumoniae and members of the Staphylococci and Enter-
obacter genera. Screening at the gene level we identified an average of 13 antimicrobial
resistance genes per preterm infant, ranging across eight different antibiotic classes,
including aminoglycosides and fluoroquinolones. Some antibiotic resistance geneswere
associated with clinically relevant bacteria, including the identification of mecA and
high levels of Staphylococci within some infants. We were able to demonstrate that in a
third of the infants the S. aureus identified was unrelated using MLST or metagenome
assembly, but low abundance prevented such analysis within the remaining samples.
Conclusions. We found that the healthy preterm infant gut microbiomes in this study
harboured a significant diversity of antibiotic resistance genes. This broad picture of
resistances and the wider taxonomic diversity identified raises further caution to the
use of antibiotics without consideration of the resident microbial communities.
Subjects Computational Biology, Genomics, Microbiology, Pediatrics, Public Health
Keywords Preterm infants, Shotgun metagenomics, Antibiotic resistance, Gut microbiome
INTRODUCTION
Over recent years the composition of the gastrointestinal (GI) microbiota has been
increasingly implicated in health and disease, with bacterial populations harbouring both
beneficial commensals and pathogens. A diverse bacterial population results in greater
genetic content, but some of this additional genetic material is less welcome. Previous
studies have implicated the GI microbiota as a reservoir of antimicrobial resistance
(AMR) genes (Penders et al., 2013), held by, or capable of being transferred to, potential
pathogens. Whilst often benign, during bacterial infection transfer of AMR genes can
occur, which—coupled with selection pressures arising through antimicrobial therapy—
can make treatment difficult, increasing the time taken to cure the infection. Furthermore,
antimicrobial therapies are generally (ideally) tailored towards acute infections targeting
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a single pathogen, with little consideration of the wider microbial communities which
reside in the microbiome, leading to a situation in which the use of antibiotics may cause
unintentional harm to the host.
As our understanding of the microbiome has developed, the collection of AMR genes
within a bacterial population has recently been defined as the resistome (Penders et
al., 2013). Antibiotics have a role in shifting the profile of the resistome within the
population (Jernberg et al., 2007), with low antibiotic-use communities harbouring lower
AMR gene frequencies (Walson et al., 2001; Bartoloni et al., 2009). Heavy treatment of
bacterial populations with antibiotics can lead to the long term overrepresentation of AMR
genes. Such dynamics are evident in the microbiome of preterm neonates, who receive
multiple antibiotic courses, and are cared for in an Intensive Care Unit environment
potentially contaminated with multi-resistant bacteria. Antibiotic treatments for both term
and preterm neonates have demonstrated lasting effects on the microbiota (Tanaka et al.,
2009; Arboleya et al., 2015), with the trajectory of population development diverging from
untreated controls, leading to a potential scenario of prolonged—even life-long—high
frequency AMR reservoirs through the selection of bacteria within the population that
are most resistant. A wide range of AMR genes have been found in neonatal populations
(De Vries et al., 2011; Zhang et al., 2011), some shown to be present from birth (Alicea-
Serrano et al., 2013; Gosalbes et al., 2016), whilst twin pairs have been shown to have GI
communities with similar distributions of both organisms and resistance genes (Moore et
al., 2015). These observations suggest vertical transmission as a source, with discrepancies
between mothers and babies being due to the substantial shifts in the microbiota adapting
to the very different environment of a newly born infant’s GI tract (Gosalbes et al., 2016).
The GI tract of a premature neonate is a particularly unusual scenario for observation
of AMR genes, due to greatly reduced bacterial immigration as a result of the isolated,
sterile environment of incubators and very controlled enteral feeds; donor breast milk may
be pasteurised and, whilst unpasteurised maternal milk (which harbours specific bacteria
(Beasley & Saris, 2004; Jimenez et al., 2008; Martin et al., 2009)) is given where possible,
there is a likelihood of little or no breastfeeding due to extreme prematurity.
In these circumstances, the GI community and the resistance genes present are likely
in the main to be derived from the mother, and acquired during birth. Whilst limited
bacterial numbers and diversity will initially be transferred, mechanisms are available for
the dissemination of AMR through the expanding bacterial population (as reviewed by
Van Hoek et al. (2011)) with transfer having been documented within the gut environment
(Shoemaker et al., 2001; Karami et al., 2007; Trobos et al., 2009). Heavy use of antibiotics
in the course of care of premature infants would not only then skew the bacterial
population and drive resistance selection, but has been shown to increase the activity
of some transposable elements due to stressing of bacterial populations (Beaber, Hochhut
& Waldor, 2004).
In this study, we present a detailed investigation of the resistome from the GI
microbiota of eleven premature infants, with detailed information on antibiotic receipt
and maternal antibiotic use. The microbiota of premature infants has been subjected
to such investigations before, but through targeted techniques such as PCR or qPCR
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(Gueimonde, Salminen & Isolauri, 2006; Alicea-Serrano et al., 2013; Von Wintersdorff et al.,
2016) or through functional metagenomics (De Vries et al., 2011;Moore et al., 2015), which
has the disadvantage of not being able to quantify the antibiotic resistance potential of
a community (Forslund et al., 2014). We have used shotgun metagenomic sequencing to
describe the resistome in its entirety, moving from species level taxonomic profiling, to
characterisation of the resistance landscape, including typing of metagenomes identified
as potentially harbouring mecA, conferring resistance to methicillin and other β-lactam
antibiotics.
MATERIALS & METHODS
Study population
The study was approved by West London Research Ethics Committee (REC) Two, United
Kingdom, under the REC approval reference number 10/H0711/39. Parents gave written
informed consent for their infant to participate in the study.
Faecal samples analysed were collected from premature infants, defined as less than 32
completed weeks of gestation. Premature infants were recruited to the study at the Imperial
College Healthcare National Health Service Trust neonatal intensive care unit (NICU), at
Queen Charlotte’s and Chelsea Hospital, between January 2010 and December 2011.
Sample collection
Almost every faecal sample produced by each participant between recruitment and
discharge was collected by nursing staff from diapers using a sterile spatula. Samples
were placed in a sterile DNase-, RNase-free Eppendorf tube, stored at −20 ◦C within two
hours of collection and stored at −80 ◦C within five days. A single faecal sample from
each of twelve infants who had no diagnosis of necrotising enterocolitis or blood-stream
infection during their admission was selected for metagenomic sequencing. DNA from one
faecal sample did not complete library preparation (see below); clinical characteristics of
the remaining eleven infants and faecal sample metadata are presented in Table S1.
DNA extraction and shotgun library preparation
DNA extractions were performed as described previously (Rose et al., 2015), but with the
following modifications: DNA extracts were prepared from approximately 200 mg of
faeces, which were re-suspended in 10× volume:weight filtered 1× phosphate-buffered
saline (PBS), with addition of 1:1 (volume:volume) 2% 2-mercaptoethanol diluted in
1× filtered PBS. The MolYsis selective lysis kit (Molzym) was used for the selective lysis of
eukaryotic cells, incorporating the modifications previously described (Rose et al., 2015).
Bacterial lysis was performed by addition of 50 µl lysozyme (Sigma), 6 µl mutanolysin
(Sigma) and 3 µl lysostaphin (Sigma) to 100 µl of re-suspended bacterial pellet, and
incubated at 37 ◦C for 1 h. This was followed by addition of 2 µl proteinase K and 150 µl
2× Tissue and Cell lysis buffer (Epicentre) and incubated at 65 ◦C for 30 min. Lysates were
added to 2 ml tubes containing 0.25 ml of 0.5 mm beads and beaten on a Fast Prep 24
system at 6 m/s for 20 s and repeated once after 5 min. Finally, DNA was purified using the
MasterPure complete kit (Epicentre) according to the manufacturer’s instructions, eluted
in 50 ul 0.1× TE buffer (Sigma) and stored at −80 ◦C.
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Extracted DNA was fragmented using the NEBNext dsDNA fragmentase kit (NEB)
according to the manufacturer’s instructions. Shotgun DNA libraries were subsequently
prepared using the KAPA HyperPrep kit (KAPA Biosystems) according to the
manufacturer’s instructions. Ligated libraries were amplified by PCR with the number
of cycles being dependant on starting material biomass, varying between two and eight
(mean three cycles). A negative extraction control was included consisting of 1 ml filtered
1× PBS and processed alongside the samples. After library amplification, the negative
extraction control and one preterm infant faecal sample required >8 PCR cycles owing
to very low starting pre-PCR biomass (DNA concentration <0.1 ng/ul), therefore these
samples were excluded from downstream analysis, leaving faecal samples from eleven
premature infants.
Shotgun metagenomic sequencing
Library insert size and quantity was assessed for each sample by Bioanalyser and qPCR as
described previously (Rose et al., 2015). Library insert size ranged from 244 bp to 288 bp
with a mean of 261 bp. Libraries were sequenced on either an Illumina NextSeq 500 system
or part of replicate runs on an Illumina MiSeq system. Prior to loading, libraries were
normalised, pooled and diluted to either 1.6 pM or 18 pM for sequencing on the NextSeq
or on the MiSeq, respectively. Paired end (PE) sequencing was performed on the NextSeq
using a v2 300 cycle high output reagent kit (Illumina) and on the MiSeq using the v3 600
cycle reagent kit (Illumina).
Prior to sequencing the complete dataset, three libraries from three infant faecal samples
were sequenced as part of separate multiplexed MiSeq runs, generating a mean 8.3 million
PE reads and 5.0 Gbp sequence yield per sample. Later sequencing on a NextSeq instrument
included the complete 11 sample set, and inclusion of a technical replicate (sample Q89).
A mean 10.0 million PE reads were generated per sample, yielding 3.0 Gbp.
Sequencing data availability
All sequencing data generated for this study is available from the EBI European Nucleotide
Archive, under study accession PRJEB15257.
Processing of metagenomic sequences
Sequence quality was calculated using FastQC (v0.11.3) (Andrews, 2010). Read filtering was
performed using Trimmomatic (v0.32) (Bolger, Lohse & Usadel, 2014). This consisted of
adapter sequence removal based on an in house database of Illumina adapters, primers and
index sequences using non-default parameters (ILLUMINACLIP 2:30:10), and subsequent
read trimming consisting of an initial head crop of the first 15 bp, then iterative removal
of leading and trailing bp with phred qualities <20, and internal bases where mean base
phred qualities <20 in 4 bp sliding windows (parameters were: LEADING:20 TRAILING:20
SLIDINGWINDOW:4:20). Finally sequences with less than 40 bp remaining were discarded
(MINLEN:40).
A mapping based approach was used to remove expected human host sequences from
the faecal samples, as well as any remaining vector contamination. Using FastQ Screen
(v0.4.4) (Babraham Institute) and the short read aligner Bowtie2 (v2.2.6) (Langmead &
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Salzberg, 2012), reads were mapped against the human genome (GRCh38) and the UniVec
(version 8) vector database (non-default parameters were: –aligner bowtie2, –nohits). All
unmapped PE reads were output as new fastq files and continued within downstream
analysis.
TheMiSeq replicate datasets entered an identical workflow, except for an additional step
designed to utilise the longer read lengths by joining the read pairs using FLASH (v1.2.11)
(Magoč & Salzberg, 2011) (–max-overlap 200), thus generating longer single sequences
(mean length 207 bp).
Species identification and relative abundances
Primarymetagenomic profiling was performed using DIAMOND (v.0.7.9.8) (Buchfink, Xie
& Huson, 2014) and MEGAN (v5.10.6) (Huson et al., 2007). All forward reads, or joined
reads in the case of the MiSeq dataset, were aligned against a protein reference database
under default parameters. The protein database was built using all 73,055,898 sequences
from the NCBI non-redundant (nr) database (downloaded 21-10-15).
Processing and taxonomic analysis of the sequence reads with matches to the nr database
was performed within MEGAN and under non-default parameters. Sequences were
assigned to the NCBI Taxonomy (1,266,115 individual taxa) using the Lowest Common
Ancestor (LCA) and the following thresholds: minimum bit-score: 80; max expectation
value: 1.0×10−6; top percentage of hits considered: 10%; minimum taxon support based
on all assigned reads: 0.01%. Relative abundances and extraction of species specific binned
reads were calculated within MEGAN.
A secondary taxonomic profiling method, MetaPhlAn (v.2.2.0) (Truong et al., 2015)
was used on all samples with the following parameters: –mpa_pkl metaphlan2/db_
v20/mpa_v20_m200.pkl –bowtie2db metaphlan2/db_v20/mpa_v20_m200 –input_type fastq.
Relative abundance tables were combined using the packaged MetaPhlAn script—
merge_metaphlan_tables.py.
Identifying antimicrobial resistance genes
Presence/absence testing of AMR genes within the samples was performed on unassembled
reads. Reads were mapped using bowtie2 (v.2.2.6) (Langmead & Salzberg, 2012) as part
of SRST2 (v0.1.7) (Inouye et al., 2014) under default parameters to a clustered ARG-
Annot database of acquired resistance genes (Gupta et al., 2014) and all hits recorded
(–gene_db srst2/data/ARGannot.r1.fasta). Default parameters set AMR gene reporting at
90% minimum coverage cutoff. Computational S. aureus sequence typing (ST) was also
performed using SRST2 (Inouye et al., 2014) under default scoring parameters, and using
the S. aureus MLST schema downloaded on 18-04-16 from pubmlst.org. Alleles were
flagged uncertain when below threshold depths (–min_edge_depth 2, –min_depth 5).
Metagenome assembly and S. aureus phylogeny
Assemblies were performed using spades (v3.7.1) under default parameters except
identification of the data as metagenomic (–meta). Assembled contigs were used as
blastn queries against the NBCI nt database, and taxonomic labels attached using MEGAN,
with all contigs identified as S. aureus (NCBI taxon id: 1280) including summarised contigs
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extracted per sample. As a reference, all S. aureus complete genomes were downloaded
from PATRIC (Release May 2016), totalling 118 genomes.
An anchor based phylogenetic method, andi (v.0.10) (Haubold, Klötzl & Pfaffelhuber,
2015), was used to estimate the evolutionary distances between the study and global S.
aureus genomes set, using PHYLIP (v.3.696) (Felsenstein, 1989) to infer the neighbour-
joining phylogeny. Following assembly, very short binned S. aureus contigs (<1 kb) and
partial assemblies, in this case those with less than half of the median S. aureus genome
size (<1.5 Mb), were excluded from andi and phylogenetic tree construction as based on
recommended guidelines (Haubold, Klötzl & Pfaffelhuber, 2015).
S. aureus typing
Experimental confirmation of mecA was attempted for all eleven samples. Faecal samples
were cultivated on the Staphylococcal selective growth media manitol salt agar. Sweeps of
the presumptive Staphylococcus colonies from each sample were propagated and extracted
by the following protocol: half a 10 µl loop of overnight growth at 35 ◦C was inoculated
into 2 ml tubes containing 0.5 mm silica/zirconia beads filled to the 0.25 ml mark and
350 µl of Master Pure Tissue Cell Lysis Buffer (EpiCentre). Bead beating was performed
using a Fast Prep (MPBio) at 6 m/s for 20 s. This was repeated three times with a 5 min
pause between each pulse. Lysates were centrifuged at 8,000× g for 10 min and 300 µl of
supernatant transferred to a new tube. A knownmecA positive strain (NCTC strain 12232)
and a mecA negative clinical isolate were used as control strains.
A multiplexed PCR method was used to type the SCCmec element within the samples
according to the protocol described previously (Milheiric¸o, Oliveira & De Lencastre, 2007),
but with the following exceptions. Each 50 µl PCR reaction consisted of 1×HotStart Ready
Mix (KAPA Biosystems), 25 ng genomic DNA, and primers at the described concentration.
The cycling conditions were as follows: 95 ◦C for 3 min followed by 30 cycles of 98 ◦C for
20 s, 53 ◦C for 30 s and 72 ◦C for 30 s followed by a final extension of 72 ◦C for 4 min.
Amplicons were purified using the AgenCourt AMpure XP PCR purification kit (Beckman
Coulter) followingmanufacturer’s instructions. Amplicon sizes were determinedmeasured
by BioAnalyser (Agilent) on a high sensitivity DNA chip, with classification of a positive
result based on fragment sizes±5 bp of those expected, and peak concentration≥500 pg/ul.
In addition to the above controls, extraction and PCR negative controls were included,
which substituted input genomic DNA for purified water.
Statistics
Species richness and the evenness of their abundance were quantified using the Shannon–
Weaver index ecological measure, calculated within MEGAN. Visualisation of samples was
performed by hierarchical clustering using the UPGMA method and principal coordinates
analysis (PCoA), all based on a matrix of Bray–Curtis distances calculated within MEGAN.
Correlations and t -tests were performed within R (v 3.2.5) (R Developement Core Team,
2015).
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Table 1 Metagenomic study dataset. Sequencing results for the eleven preterm samples sequenced and four replicates.
Sample Instrument Read
length
Raw PE reads Surviving PE
reads*
Surviving
PE reads %*
Mean read
length (bp)
Yield
(Gbps)
Q19 NextSeq 151 10,765,181 9,748,620 90.6 118.5 2.3
Q26 NextSeq 151 10,515,261 9,675,994 92.0 125.3 2.4
Q83 NextSeq 151 10,272,541 9,434,574 91.8 128.1 2.4
Q87 NextSeq 151 9,771,928 9,031,166 92.4 126.3 2.3
Q89 NextSeq 151 10,573,383 9,686,447 91.6 130.5 2.5
Q89 (r) NextSeq 151 10,746,440 9,824,221 91.4 129.1 2.5
Q117 NextSeq 151 9,718,743 8,943,195 92.0 124.4 2.2
Q142 NextSeq 151 9,847,000 9,059,108 92.0 129.0 2.3
Q175 NextSeq 151 11,442,761 10,404,737 90.9 121.1 2.5
Q189 NextSeq 151 9,385,745 8,667,469 92.3 125.2 2.2
Q216 NextSeq 151 11,842,425 10,963,555 92.6 125.8 2.8
Q219 NextSeq 151 5,761,388 5,295,708 91.9 118.4 1.3
Q87 (r) MiSeq 301 8,061,151 5,710,557 70.8 193.0 1.1
Q142 (r) MiSeq 301 4,101,014 3,234,121 78.9 204.1 0.7
Q216 (r) MiSeq 301 12,778,363 10,848,709 84.9 224.0 2.4
Mean – – 9,705,555 8,701,879 – – 2.1
Total – – 145,583,324 130,528,181 89.7 – –
Notes.
*Three MiSeq replicate samples paired reads were merged during QC, therefore read number represent single reads.
(r) signifies replicate samples.
RESULTS
The healthy preterm metagenome
Using shotgun metagenomic sequencing we have captured an early snapshot of the
antimicrobial resistance landscape within the gut microbiota of eleven premature infants
who did not have proven sepsis or necrotizing enterocolitis. Infants were born either
vaginally (N = 6) or by caesarean section (N = 5), with gestational ages ranging 24–31
weeks (mean 26.9 weeks). Ages of the infants at which the samples were taken ranged from
5 to 43 days (mean 25.7 days) (Table S1). A mixture of benchtop to medium throughput
Illumina platforms were used to generate a dataset of 145.6 million paired end (PE)
reads (51.4 Gbp sequence data) (Table 1), enabling us to characterise taxonomic and
antimicrobial resistance profiles.
The eleven sequenced samples and four replicates were analysed using a blastx type
analysis with filtering by the Lowest Common Ancestor (Huson et al., 2007; Buchfink,
Xie & Huson, 2014), which enabled assignment of taxonomic labels for 71.5% of the
reads within the complete dataset to at least the level of Kingdom (Table S2). As an
alternative method, we also profiled the dataset using a marker based approach (Truong
et al., 2015), which was highly congruent to species level relative abundances, as well as
higher taxonomic ranks, to the blast based method used (Pearson R= 0.9–1.0) (Table S3).
Replicate sequencing of samples also demonstrated reproducibility of the method, either
by cluster analysis (Fig. 1) or pairwise correlations (Fig. S1).
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Figure 1 Healthy premature infant gut microbiome. (A) Metagenomic profiles for the eleven preterm
samples and four replicates at the species level. Samples clustered by UPGMA using Bray–Curtis distances
shown on left, with replicates highlighted by filled nodes. Relative abundances by rank order shown on
right, with the top 8 most abundant species coloured and labelled, leaving remaining species in white. (B)
Dominant species, based on ≥50% abundance, shown on x-axis, with overall prevalence of the species
across samples shown on y-axis. Sample number reflects eleven neonates as replicates are averaged. The
five labelled species are present in five or more samples with at least one in >50% abundance. (C) Prin-
cipal coordinates analysis (PCoA) using Bray–Curtis distances at the species level for all fifteen samples.
Separation of the three broad sample groups shown by biplot of the top five species.
Moving to taxonomic composition, each sample was marked by a few highly abundant
species, such as sample Q216 with 85.1% Clostridium perfringens, Q189 with 73.1%
Klebsiella pneumoniae, and Q83 with 85.9% Enterococcus faecalis (Fig. 1A). In terms of
prevalence, the previous three species, as well as Enterobacter cloacae and Staphylococcus
epidermidis, were found at over 50% relative abundance in one or more samples.
Furthermore, S. epidermidis and S. aureus were ubiquitous, ranging from 0.06% to 57.1%
abundance in all samples (Fig. 1B). Principal coordinate analysis (PCoA) demonstrated
three loose sample groups based on a high abundance of S. epidermidis,K. pneumoniae, and
either B. breve, S. aureus or C. perfringens (Fig. 1C). In total we identified a non-redundant
set of 172 species across all samples (see Table S4 for complete dataset).
Prevalence of antimicrobial resistance
Before focusing on individual AMR genes, we measured the α-diversity (Shannon–
Weaver index) within each sample and, although a small sample set, compared this to
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Figure 2 Antibiotic resistance genes detected.Heatmap showing distribution of the 39 AMR genes
detected within the eleven metagenomic samples. Genes grouped by antibiotic class are demarcated by
black lines under gene names: AGly (aminoglycosides), Bla (β-lactam), Fos (Fosfomycin), Flq (fluoro-
quinolones), MLS (macrolide-lincosamide- streptogramin), Phe (phenicols), Tet (tetracyclines), Tmt
(trimethoprim). Colours show read depth in bp: undetected (grey), 3–199 bp (blue), 200–399 bp (yellow),
400–1,437 (red). Rows clustered by UPGMA method using Euclidean distances.
the known antibiotic exposure of the preterm infants (Fig. S2). Eight of the eleven infants
had received a course of prophylactic antibiotic treatment consisting of co-amoxiclav
(Table S1), whilst a second course was administered to four infants, consisting of
combinations of co-amoxiclav, tazocin or vancomycin. In total, exposure ranged from
2 to 8 days of antibiotics before samples were taken, excluding infants Q87 and Q89 which
received no antibiotics. Antibiotics were also administeredmaternally to three infants (Q26,
Q117 & Q189), but this did not include the two above infants with no antibiotic treatment.
Sample diversity ranged from 0.9 to 2.9 (SD ± 0.5), but when compared to cumulative
antibiotic exposure expressed in days, no significant difference was found between the
taxonomic diversity and amount of antibiotic exposure for untreated and treated infants
(unpaired t -test, P = 0.17) (Fig. S2). However, it is important to stress that the small and
heterogeneous nature of the sample set will have reduced the power to detect differences
between antibiotic exposure in this study, and so prevented any meaningful stratification
by other clinical variables such as mode of delivery or day of life.
A mapping based approach against a comprehensive collection of acquired antibiotic
resistance genes was next used to quantify AMR within the eleven metagenomes (Inouye
et al., 2014). In total 143 AMR genes were identified, consisting of a non-redundant set
of 39 different AMR genes (Fig. 2 and Table S5). Per infant, the average number of genes
identified was 13 (ranging 5–22 genes), and AMR genes were found across eight different
antibiotic classes, including aminoglycosides and fluoroquinolones (Table S6). Mean
sequence coverage across the sequence database was 99.0%, and sequence divergence
ranged from no difference to 12.3% (Table S6). In total over 1,600 alleles were searched
for, and notable AMR genes not detected included those involved in carbapenem and
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Table 2 Antibiotic classes identified.Major antibiotic resistant classes of genes identified within the
eleven samples by SRST2. Columns show antibiotic type and number of genes found within class.
Antibiotic type Number of identified genes within class
β-lactam (Bla) 10
Macrolide-lincosamide- streptogramin (MLS) 9
Aminoglycosides (AGly) 7
Tetracyclines (Tet) 5
Fluoroquinolones (Flq) 3
Phenicols (Phe) 2
Trimethoprim (Tmt) 2
Fosfomycin (Fcyn) 1
vancomycin resistance, the latter of which was administered to three preterm infants prior
to sample collection (Table S1). The class most frequently detected were β-lactamases,
comprising ten different genes (Table 2), of which the blaZ gene was present in every
infant. Interestingly, within this set of β-lactamase genes, mecA was found in four infants
(Q87, Q117, Q175, and Q189), and at a mean depth of coverage ranging from 3.9 to 52.2
bp (Fig. 2). mecA confers resistance to methicillin as well as other β-lactam antibiotics,
and is carried on the SCCmec mobile element found across several Staphylococci species.
Identification of four infants with potential methicillin resistant S. aureus (MRSA) or S.
epidermidis (MRSE) carriage, along with high abundances and prevalence of both S. aureus
and S. epidermidis species across the dataset, could indicate a significant reservoir for AMR
transfer between the species, as well as highlight the seeding of the infant gut microbiome
from an early stage.
Focus on S. aureus species detected
Next, we wanted to understand the relationship of the S. aureus species within the mecA
positive as well as negative samples, as the premature infants overlapped in time and
so could harbour closely related strains. This was undertaken to firstly confirm in silico
prediction of mecA using an established molecular based typing method, but also to
push the metagenomic analysis further on what was known to be a challenging dataset
owing to the range of identified S. aureus as described above, with relative abundance
ranging from 0.06% to 39.8% (Table S4). We first tested the computational prediction of
mecA experimentally using a multiplexed PCR typing method (Milheiric¸o, Oliveira & De
Lencastre, 2007), which provides detection of the mecA gene, in addition to typing of the
mobile element carrying the gene (SCCmec), although this component of the assay was
beyond the scope of this study. Using this method we detected mecA presence correctly
within the control strains, a methicillin resistant (MRSA) and susceptible (MSSA) strain
(see ‘Materials & Methods’), and three out of the four predicted mecA positive samples
generated a positive mecA result (Table S7). The exception, sample Q87, generated the
expected mecA amplicon size but the concentration of this fell below the threshold for
detection (<500 pg/ul) and so was excluded.
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In an attempt to understand strain relatedness directly from the metagenomic data,
we undertook in silico MLST analysis using an S. aureus schema as well as metagenome
assembly. The MLST was able to classify four of the eleven samples, all with different ST
types—ST8, ST1027, ST22, ST25, although the last two had some degree of uncertainty in
their assignment (Table S8). This suggests that for at least these four samples, the S. aureus
strains are unrelated and unlikely a result of transmission. We were interested to know
if de novo assembly of the metagenome could be utilised to resolve these and any of the
remaining unclassifiable samples further. Following assembly and identification of S. aureus
contigs (see ‘Materials &Methods’), we found that it was not possible to capture more than
a fifth of the expected genome size for the above unclassified samples, with an abundance
of >3% necessary to achieve over 90% estimated capture, which was achieved in four
cases (Table S9). Phylogenetic reconstruction of these four genomes alongside a collection
of published S. aureus genomes (Table S10), provided confirmation of the diversity
of S. aureus identified (Fig. S3), enabling placement across a global collection of strains.
DISCUSSION
It is recognised that one of the most important public health threats worldwide is
antimicrobial resistance. Here we report on the gut composition and AMR diversity
for eleven healthy but premature infants. Recent studies have shown that the initial seeding
of the infant gut microbiome is influenced by the microorganisms in the immediate
environment, and whilst colonisation by bacteria with AMR genes has been demonstrated
(Brooks et al., 2014), comparatively far fewer studies have investigated the gut microbiome
of infants, fewer still preterm healthy infants. Interest has also increased on how the
trajectory of the early gut microbiome is influenced to form the ‘stable’ adult microbiome.
The preterm infant gutmicrobiome is very different compared to full-term infants (Groer et
al., 2014), displaying a much lower diversity, particularly in anaerobes, with an increase in
coagulase-negative Staphylococci and Enterobacteriaceae (Adlerberth & Wold, 2009); adult
microbiomes are characterised by several hundred, mostly anaerobic bacterial species
(Adlerberth & Wold, 2009). We found a similarly low level of species diversity across all
metagenomes, with each sample dominated by a few highly abundant species, including
C. perfringens, K. pneumoniae and members of the Staphylococci and Enterobacter genera.
Presence of such species are in common with previous studies on the premature gut
microbiome (Groer et al., 2014; Gibson et al., 2016).
Interestingly, each metagenome profile displayed a different dominant few species,
clustering into three loose groupings. This could reflect the dynamic nature of the early
establishing gut, with the preterm infant microbiome acquiring an increased diversity of
bacteria and subjected to a great amount of change until it matures into what is recognised
as a more ‘stable’ microbiome. Although we found no correlation between diversity and
antibiotic exposure, with infants treated with either no antibiotics (including during
pregnancy), to up to 8 days of antibiotic administration, effects such as relatively small
sample size, as well as day of life of sample and normal gut development are biases to
this finding, which is contrary to other studies within infants (Greenwood et al., 2014;
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Merker et al., 2015). It could be that at this very early stage, the microbiota is influenced to
a greater extent by seeding during birth from the mother and environment than antibiotic
treatment, or that not enough time has passed to detect differences from the antibiotics
administered; larger sample numbers would be required, alongside longitudinal studies
and parallel maternal sampling to better understand the development of diversity.
A threat to this development is the acquisition of antibiotic resistant bacteria, which
can potentially seed the infant microbiome. Coupled with the high rate of horizontal gene
transfer within the commensal community (Stecher et al., 2012), the preterm infant gut
microbiome has the potential to be a reservoir for AMR. With dominance of the preterm
gut by species known to carry clinically relevant antibiotic resistance, we next quantified
the burden of antibiotic resistance genes within the infant’s faecal flora, which identified
an average of 13 genes per infant. Previous targeted or functional studies based on infants
have found some of the AMR genes also identified here, including those for Tetracycline
(tet ) (Gueimonde, Salminen & Isolauri, 2006; Alicea-Serrano et al., 2013) and β-lactam
(bla) (Fouhy et al., 2014). In a wider context, it is known that AMR genes are a common
feature of bacterial populations, found in communities inhabiting the soil, rivers and even
deep-sea sediment (Knapp et al., 2010; Qin et al., 2011; Kittinger et al., 2016). Therefore,
whilst their presence in the human gut microbiome should be of little surprise (Bailey et al.,
2010), identification of genes such as mecA demonstrates the prevalence of some clinically
significant resistant bacteria from birth.
One of the advantages of the method used in this study is the utility of the results
generated, enabling multiple avenues of questions to be addressed. However, short read
sequencing remains a challenge when applied to the linkage of resistance elements, such
mecA, to specific genome sequences (strains), which is made difficult by the nature of
metagenomic samples containing multiple alleles from different closely related species,
as well as potentially multiple strains of the same species. Secondly, the methods used
here were inherently restricted to identification of known AMR genes found within the
ARGannot database used in this study, which contains those genes involved in acquired
resistance only, therefore chromosomal mutations, such as those conferring resistance to
rifampicin as well as novel resistance genes would have been missed, leading to potential
underrepresentation of resistance in this study.
CONCLUSIONS
The healthy preterm infants sampled within this study harboured multiple AMR genes,
representing a potential reservoir for later disease onset. In particular, detection of clinically
important AMR genes, such as mecA, highlights the need to further understand the
impact that this reservoir could have on later treatment regimes. From a methodology
point, this approach was able to provide a comprehensive snapshot of the complete
taxonomic diversity and resistome in one assay. Although tracking of the movement of
such AMR genetic elements would be enhanced by improved handling of the dynamic
ranges of abundances; different methods at the level of sample preparation, such as sample
normalisation, may offer potential answers to such hurdles. Overall this study leads to
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questions such as how this resistance potential contributes to later clinical intervention or
disease onset, and if antibiotic treatment without knowledge of prior AMR burden could
lead to unintentional harm. More broadly, this and other studies show the great promise
that shotgun metagenomics holds for clinical microbiology.
Abbreviations
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PCR polymerase chain reaction
qPCR quantitative polymerase chain reaction
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